Andrew Fisher - 01 Apr 2024 Form 4 Insider Report for Verona Pharma plc (VRNA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRNA	Share Options (Right to Buy)	Award	$0	+2.4M		$0.00	2.4M	01 Apr 2024	Ordinary Shares	2.4M	$2.01	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2	The option vests and becomes exercisable as to 25% on March 4, 2025. The remainder of the shares will vest in 36 equal monthly installments thereafter.